| abstract |
The present invention provides a therapeutic agent for a tumor selected from a hematopoietic tumor and a solid tumor which comprises, as an active ingredient, a benzoyl compound represented by General Formula (I): n n n n n n n n n n (whereinn nn represents an integer of 1 to 5;n nR 1 represents substituted or unsubstituted lower alkoxy, substituted or unsubstituted lower alkoxycarbonyl, CONR 7 R 8 or the like;n nR 2 represents substituted or unsubstituted aryl or a substituted or unsubstituted aromatic heterocyclic group;n nR 3 and R 5 may be the same or different, and each represents a hydrogen atom, substituted or unsubstituted lower alkyl or the like;n nR 4 represents a hydrogen atom, hydroxy or halogen; andn nR 6 represents a hydrogen atom, halogen, substituted or unsubstituted lower alkyl or the like), a prodrug thereof or a pharmaceutically acceptable salt thereof. |